Biocon names Peter Bains as Group CEO
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
The products will be manufactured at the company's facility in Bengaluru
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Subscribe To Our Newsletter & Stay Updated